5-Fluorouracil Derivatives. X
With the aim of diminishing the toxicity of 5-fluorouracil (1) and obtaining biologically active derivatives of 1 suitable for oral administration, α-alkoxyalkyl groups were introduced at the 1-, 3-and 1, 3-positions of 1. Alkoxyalkylation can be effected by four methods : (i) reaction of 1-alkoxyal...
Gespeichert in:
Veröffentlicht in: | Chemical & pharmaceutical bulletin 1986-01, Vol.34 (1), p.150 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 1 |
container_start_page | 150 |
container_title | Chemical & pharmaceutical bulletin |
container_volume | 34 |
creator | OZAKI, SHOICHIRO WATANABE, YUTAKA HOSHIKO, TOMONORI NAGASE, TOSHIO OGASAWARA, TOMIO FURUKAWA, HIROYUKI UEMURA, ATSUHIKO ISHIKAWA, KATSUTOSHI MORI, HARUKI HOSHI, AKIO IIGO, MASAAKI TOKUZEN, REIKO |
description | With the aim of diminishing the toxicity of 5-fluorouracil (1) and obtaining biologically active derivatives of 1 suitable for oral administration, α-alkoxyalkyl groups were introduced at the 1-, 3-and 1, 3-positions of 1. Alkoxyalkylation can be effected by four methods : (i) reaction of 1-alkoxyalkyl chloride (2) with 1, (ii) reaction of acetal with 2, 4-bis (trimethylsiloxy)-5-fluoropy-rimidine, (iii) addition reaction of α-unsaturated ether with 1, (iv) aminolysis of 1-alkylthio-carbonyl-3-(1-alkoxyalkyl)-5-fluorouracil. The toxicity of the products was less than that of 1, and some of these compounds showed moderate antitumor activity against L-1210 leukemia. |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1460088066</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3132279441</sourcerecordid><originalsourceid>FETCH-proquest_journals_14600880663</originalsourceid><addsrcrecordid>eNpjYuA0NDYx1zU1MjJmYeA0MDCw1DUyNjPmYOAqLs4yMDAyNTA35mSQNdV1yynNL8ovLUpMzsxRcEktyixLLMksSy3WU4jgYWBNS8wpTuWF0twMym6uIc4eugVF-YWlqcUl8VlAjXlAqXhDEzMDAwsLAzMzY-JUAQDxvyzI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1460088066</pqid></control><display><type>article</type><title>5-Fluorouracil Derivatives. X</title><source>J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Free Full-Text Journals in Chemistry</source><creator>OZAKI, SHOICHIRO ; WATANABE, YUTAKA ; HOSHIKO, TOMONORI ; NAGASE, TOSHIO ; OGASAWARA, TOMIO ; FURUKAWA, HIROYUKI ; UEMURA, ATSUHIKO ; ISHIKAWA, KATSUTOSHI ; MORI, HARUKI ; HOSHI, AKIO ; IIGO, MASAAKI ; TOKUZEN, REIKO</creator><creatorcontrib>OZAKI, SHOICHIRO ; WATANABE, YUTAKA ; HOSHIKO, TOMONORI ; NAGASE, TOSHIO ; OGASAWARA, TOMIO ; FURUKAWA, HIROYUKI ; UEMURA, ATSUHIKO ; ISHIKAWA, KATSUTOSHI ; MORI, HARUKI ; HOSHI, AKIO ; IIGO, MASAAKI ; TOKUZEN, REIKO</creatorcontrib><description>With the aim of diminishing the toxicity of 5-fluorouracil (1) and obtaining biologically active derivatives of 1 suitable for oral administration, α-alkoxyalkyl groups were introduced at the 1-, 3-and 1, 3-positions of 1. Alkoxyalkylation can be effected by four methods : (i) reaction of 1-alkoxyalkyl chloride (2) with 1, (ii) reaction of acetal with 2, 4-bis (trimethylsiloxy)-5-fluoropy-rimidine, (iii) addition reaction of α-unsaturated ether with 1, (iv) aminolysis of 1-alkylthio-carbonyl-3-(1-alkoxyalkyl)-5-fluorouracil. The toxicity of the products was less than that of 1, and some of these compounds showed moderate antitumor activity against L-1210 leukemia.</description><identifier>ISSN: 0009-2363</identifier><identifier>EISSN: 1347-5223</identifier><language>eng</language><publisher>Tokyo: Japan Science and Technology Agency</publisher><ispartof>Chemical & pharmaceutical bulletin, 1986-01, Vol.34 (1), p.150</ispartof><rights>Copyright Japan Science and Technology Agency 1986</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>OZAKI, SHOICHIRO</creatorcontrib><creatorcontrib>WATANABE, YUTAKA</creatorcontrib><creatorcontrib>HOSHIKO, TOMONORI</creatorcontrib><creatorcontrib>NAGASE, TOSHIO</creatorcontrib><creatorcontrib>OGASAWARA, TOMIO</creatorcontrib><creatorcontrib>FURUKAWA, HIROYUKI</creatorcontrib><creatorcontrib>UEMURA, ATSUHIKO</creatorcontrib><creatorcontrib>ISHIKAWA, KATSUTOSHI</creatorcontrib><creatorcontrib>MORI, HARUKI</creatorcontrib><creatorcontrib>HOSHI, AKIO</creatorcontrib><creatorcontrib>IIGO, MASAAKI</creatorcontrib><creatorcontrib>TOKUZEN, REIKO</creatorcontrib><title>5-Fluorouracil Derivatives. X</title><title>Chemical & pharmaceutical bulletin</title><description>With the aim of diminishing the toxicity of 5-fluorouracil (1) and obtaining biologically active derivatives of 1 suitable for oral administration, α-alkoxyalkyl groups were introduced at the 1-, 3-and 1, 3-positions of 1. Alkoxyalkylation can be effected by four methods : (i) reaction of 1-alkoxyalkyl chloride (2) with 1, (ii) reaction of acetal with 2, 4-bis (trimethylsiloxy)-5-fluoropy-rimidine, (iii) addition reaction of α-unsaturated ether with 1, (iv) aminolysis of 1-alkylthio-carbonyl-3-(1-alkoxyalkyl)-5-fluorouracil. The toxicity of the products was less than that of 1, and some of these compounds showed moderate antitumor activity against L-1210 leukemia.</description><issn>0009-2363</issn><issn>1347-5223</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><recordid>eNpjYuA0NDYx1zU1MjJmYeA0MDCw1DUyNjPmYOAqLs4yMDAyNTA35mSQNdV1yynNL8ovLUpMzsxRcEktyixLLMksSy3WU4jgYWBNS8wpTuWF0twMym6uIc4eugVF-YWlqcUl8VlAjXlAqXhDEzMDAwsLAzMzY-JUAQDxvyzI</recordid><startdate>19860101</startdate><enddate>19860101</enddate><creator>OZAKI, SHOICHIRO</creator><creator>WATANABE, YUTAKA</creator><creator>HOSHIKO, TOMONORI</creator><creator>NAGASE, TOSHIO</creator><creator>OGASAWARA, TOMIO</creator><creator>FURUKAWA, HIROYUKI</creator><creator>UEMURA, ATSUHIKO</creator><creator>ISHIKAWA, KATSUTOSHI</creator><creator>MORI, HARUKI</creator><creator>HOSHI, AKIO</creator><creator>IIGO, MASAAKI</creator><creator>TOKUZEN, REIKO</creator><general>Japan Science and Technology Agency</general><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>19860101</creationdate><title>5-Fluorouracil Derivatives. X</title><author>OZAKI, SHOICHIRO ; WATANABE, YUTAKA ; HOSHIKO, TOMONORI ; NAGASE, TOSHIO ; OGASAWARA, TOMIO ; FURUKAWA, HIROYUKI ; UEMURA, ATSUHIKO ; ISHIKAWA, KATSUTOSHI ; MORI, HARUKI ; HOSHI, AKIO ; IIGO, MASAAKI ; TOKUZEN, REIKO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_14600880663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>OZAKI, SHOICHIRO</creatorcontrib><creatorcontrib>WATANABE, YUTAKA</creatorcontrib><creatorcontrib>HOSHIKO, TOMONORI</creatorcontrib><creatorcontrib>NAGASE, TOSHIO</creatorcontrib><creatorcontrib>OGASAWARA, TOMIO</creatorcontrib><creatorcontrib>FURUKAWA, HIROYUKI</creatorcontrib><creatorcontrib>UEMURA, ATSUHIKO</creatorcontrib><creatorcontrib>ISHIKAWA, KATSUTOSHI</creatorcontrib><creatorcontrib>MORI, HARUKI</creatorcontrib><creatorcontrib>HOSHI, AKIO</creatorcontrib><creatorcontrib>IIGO, MASAAKI</creatorcontrib><creatorcontrib>TOKUZEN, REIKO</creatorcontrib><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Chemical & pharmaceutical bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>OZAKI, SHOICHIRO</au><au>WATANABE, YUTAKA</au><au>HOSHIKO, TOMONORI</au><au>NAGASE, TOSHIO</au><au>OGASAWARA, TOMIO</au><au>FURUKAWA, HIROYUKI</au><au>UEMURA, ATSUHIKO</au><au>ISHIKAWA, KATSUTOSHI</au><au>MORI, HARUKI</au><au>HOSHI, AKIO</au><au>IIGO, MASAAKI</au><au>TOKUZEN, REIKO</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>5-Fluorouracil Derivatives. X</atitle><jtitle>Chemical & pharmaceutical bulletin</jtitle><date>1986-01-01</date><risdate>1986</risdate><volume>34</volume><issue>1</issue><spage>150</spage><pages>150-</pages><issn>0009-2363</issn><eissn>1347-5223</eissn><abstract>With the aim of diminishing the toxicity of 5-fluorouracil (1) and obtaining biologically active derivatives of 1 suitable for oral administration, α-alkoxyalkyl groups were introduced at the 1-, 3-and 1, 3-positions of 1. Alkoxyalkylation can be effected by four methods : (i) reaction of 1-alkoxyalkyl chloride (2) with 1, (ii) reaction of acetal with 2, 4-bis (trimethylsiloxy)-5-fluoropy-rimidine, (iii) addition reaction of α-unsaturated ether with 1, (iv) aminolysis of 1-alkylthio-carbonyl-3-(1-alkoxyalkyl)-5-fluorouracil. The toxicity of the products was less than that of 1, and some of these compounds showed moderate antitumor activity against L-1210 leukemia.</abstract><cop>Tokyo</cop><pub>Japan Science and Technology Agency</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-2363 |
ispartof | Chemical & pharmaceutical bulletin, 1986-01, Vol.34 (1), p.150 |
issn | 0009-2363 1347-5223 |
language | eng |
recordid | cdi_proquest_journals_1460088066 |
source | J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese; EZB-FREE-00999 freely available EZB journals; Free Full-Text Journals in Chemistry |
title | 5-Fluorouracil Derivatives. X |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T23%3A17%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=5-Fluorouracil%20Derivatives.%20X&rft.jtitle=Chemical%20&%20pharmaceutical%20bulletin&rft.au=OZAKI,%20SHOICHIRO&rft.date=1986-01-01&rft.volume=34&rft.issue=1&rft.spage=150&rft.pages=150-&rft.issn=0009-2363&rft.eissn=1347-5223&rft_id=info:doi/&rft_dat=%3Cproquest%3E3132279441%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1460088066&rft_id=info:pmid/&rfr_iscdi=true |